Ibuprofen Dolorgiet (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, ibuprofen reduces inflammation, diminishes pain signaling, and helps lower elevated body temperature.

The specific dose of Ibuprofen Dolorgiet is determined by the prescribing healthcare professional based on the patient’s age, weight, condition being treated, and overall health status. Clinicians follow established guidelines for ibuprofen dosing but individual regimens may vary.

Safety data for Ibuprofen Dolorgiet in pregnancy and lactation are limited. Generally, ibuprofen is avoided in the third trimester and used with caution earlier in pregnancy. Breastfeeding mothers should consult a healthcare provider, as ibuprofen can be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen Dolorgiet shares the same mechanism as other non‑selective NSAIDs like naproxen and diclofenac, offering comparable analgesic and anti‑inflammatory effects. Differences may lie in pharmacokinetic profiles, dosing frequency, and individual tolerability, which clinicians consider when selecting the most appropriate NSAID for a patient.

Ibuprofen Dolorgiet should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Ibuprofen Dolorgiet is taken orally, usually with a full glass of water. It may be taken with food or milk to lessen gastrointestinal discomfort, but it can also be taken on an empty stomach if tolerated. The exact administration schedule is set by the prescriber.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, severe allergic reactions such as anaphylaxis, and increased cardiovascular events like heart attack or stroke, especially with high‑dose or prolonged use. Patients should be monitored for these complications.

Ibuprofen Dolorgiet should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulceration, severe renal or hepatic impairment, and in patients who have experienced a recent myocardial infarction or uncontrolled heart failure, unless specifically directed by a physician.